BioNTech
BNTX
BNTX
318 hedge funds and large institutions have $6.01B invested in BioNTech in 2022 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 102 increasing their positions, 84 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.06% more ownership
Funds ownership: 15.27% → 16.33% (+1.1%)
17% less call options, than puts
Call options by funds: $349M | Put options by funds: $421M
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
318
Holding in Top 10
7
Calls
$349M
Puts
$421M
Top Buyers
| 1 | +$82M | |
| 2 | +$71.1M | |
| 3 | +$66.6M | |
| 4 |
Renaissance Technologies
New York
|
+$49.8M |
| 5 |
AAM
Abeille Asset Management
France
|
+$46M |
Top Sellers
| 1 | -$103M | |
| 2 | -$71.5M | |
| 3 | -$70.9M | |
| 4 |
Twin Tree Management
Dallas,
Texas
|
-$37.6M |
| 5 |
AC
Armistice Capital
New York
|
-$17.4M |